People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Health Care, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Galvanize Therapeutics, Inc. | — | Biotechnology | Series C | $150.7M | $581.7M | 2015 |
| Aileron Therapeutics Inc | — | Biotechnology | Series B | $111.3M | $172.9M | 2009 |
| HeartWare International, Inc. | — | Other Health Care | Series C | $55.2M | $5.0M | 2009 |
| Tusker Medical, Inc. | — | Biotechnology | Series B | $53.5M | $79.4M | 2019 |
| Gloucester Pharmaceuticals Inc | — | Biotechnology | Series B | $26.0M | $806.7M | 2009 |
| Syntimmune, Inc. | — | Biotechnology | Series B | $26.0M | $714.4M | 2014 |
| Aulos Bioscience, Inc. | — | Biotechnology | Series A | $20.0M | $41.0M | 2023 |
| Replicate Bioscience, Inc. | — | Biotechnology | Series B | $20.0M | $614.0M | 2021 |
| Cure Forward Corp. | — | Other Technology | Series A | $16.3M | $124.8M | 2014 |
| Galaxy Medical, Inc. | — | Biotechnology | Series A | $10.0M | $14.3M | 2020 |
| Aethon Therapeutics, Inc. | — | Biotechnology | Series A | $6.0M | $66.2M | 2022 |
| Deep Apple Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $90.5M | 2021 |
| Red Queen Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $97.2M | 2021 |
| Nine Square Therapeutics Corp | — | Biotechnology | Series A | $4.2M | $151.8M | 2020 |
| Initial Therapeutics, Inc. | — | Biotechnology | Seed | $3.8M | $168.3M | 2020 |
| Evercrisp Biosciences, Inc. | — | Biotechnology | Seed | $3.5M | $83.9M | 2021 |
| Marlinspike Therapeutics, Inc. | — | Biotechnology | Seed | $3.5M | $64.3M | 2022 |
| Apertor Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.0M | $95.2M | 2020 |
| Galavant Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $100K | $5.5M | 2020 |
Seth Harrison at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Seth Harrison on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.